1 |
IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation |
CD3ϵ, B220, CD11b, CD11c, Gr-1, NK1.1, and FcϵRI |
(27) |
2 |
IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow |
CD3, CD5, CD45R (B220), CD11b, Gr-1 (Ly-6G/C), 7-4, and Ter-119 |
(28) |
3 |
IL-25-responsive, lineage-negative KLRG1hi cells are multipotential “inflammatory” type 2 innate lymphoid cells |
CD3ϵ, CD5, CD19, B220, TCRγδ, NK1.1, CD11b, CD11c, Gr-1, FcϵR1, and TER119 |
(29) |
4 |
A tissue checkpoint regulates type 2 immunity |
B220, CD11b, CD19, TCRgd, CD11c, CD3, CD5, Ter 119, NK 1.1, and CD8 |
(30) |